icon-folder.gif   Conference Reports for NATAP  
 
  ICAAC 2015 55th Interscience Conference
on Antimicrobial Agents and Chemotherapy
September 5-9, 2015, San Diego, CA
Back grey_arrow_rt.gif
 
 
 
Safety of Once-Daily Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide in Participants With Glomerular Filtration Rate <50 mL/min: 48-Week Results
 
 
  Reported by Jules Levin
ICAAC 2015 Sept 17-21 San Diego, CA
 
Samir K. Gupta,1 Frank Post,2 Anton Pozniak,3 James McMahon,4 Anchalee Avihingsanon,5 Jihad Slim,6 Robert Grossberg,7 Anne Khalsa,8 Joseph Custodio,9 Michael Abram,9 Xuelian Wei,9 Andrew Cheng,9 Scott McCallister,9 Marshall W. Fordyce9
 
1Indiana University School of Medicine, Indianapolis, IN; 2King's College Hospital NHS Foundation Trust, London, UK; 3Chelsea and Westminster Hospital NHS Foundation Trust, London; 4Burnet Institute, Melbourne, Australia; 5HIV-NAT, Thai Red Cross AIDS Research Center, Prathumwan, Thailand; 6Saint Michael's Medical Center, Newark, NJ; 7Center for Positive Living/ID Clinic, Montefiore Medical Center, Bronx, NY; 8Maricopa Integrated Health System-McDowell Clinic, Phoenix, AZ; 9Gilead Sciences, Inc., Foster City, CA

ICAAC1.gif

ICAAC2.gif

ICAAC3.gif

ICAAC4.gif

ICAAC5.gif

ICAAC6.gif

ICAAC7.gif

ICAAC8.gif

ICAAC9.gif

ICAAC10.gif

ICAAC11.gif

ICAAC12.gif